Literature DB >> 1520527

Carbohydrate changes in bladder carcinomas.

T F Orntoft1.   

Abstract

The cloning of glycosyltransferases is a major breakthrough in the study of glycosylation in normal an malignant tissue. In bladder tumours we need a molecular explanation for the changes observed in especially Gal alpha 1-3 and GalNac alpha 1-3 transferase activity. Studies of the events (transcription/translation) taking place in the different cell layers would also be of importance, especially if the cells could be sorted layer by layer. The urine is a source of malignant cells, and could be a target for diagnosis as well as monitoring. Studies of urinary tumour-associated glycoconjugates or tumour-associated rearrangements in glycosyltransferase genes in exfoliated cells would be of great interest.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1520527

Source DB:  PubMed          Journal:  APMIS Suppl        ISSN: 0903-465X


  5 in total

1.  Carbohydrate Antigens as Oncofetal Antigens in Papillary Carcinoma of the Thyroid Gland.

Authors:  Elsa Fonseca; Salome Castanhas; Manuel Sobrinho-Simoes
Journal:  Endocr Pathol       Date:  1997       Impact factor: 3.943

2.  Protein glycosylation in cancer biology: an overview.

Authors:  F Dall'olio
Journal:  Clin Mol Pathol       Date:  1996-06

3.  Chronic treatment with epidermal growth factor causes esophageal epithelial hyperplasia in pigs and rats.

Authors:  C O Juhl; L Vinter-Jensen; S S Poulsen; T F Orntoft; E Z Dajani
Journal:  Dig Dis Sci       Date:  1995-12       Impact factor: 3.199

4.  Characterisation of the anti-bladder-cancer monoclonal antibody BLCA-8: identification of its antigen as a neutral glycolipid.

Authors:  E A Kingsley; T E Carter; K D Barrow; P J Russell
Journal:  Cancer Immunol Immunother       Date:  1995-12       Impact factor: 6.968

5.  Losses of expression of the antigens A, Lea and Lex and over-expression of Ley in carcinomas and HG-SIL of the uterine cervix.

Authors:  Ernesto Moro-Rodríguez; Emilio Alvarez-Fernández
Journal:  Diagn Pathol       Date:  2008-09-11       Impact factor: 2.644

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.